Skip to content

PURE Bioscience, Inc.: filings

Every PURE Bioscience, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 59 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-06-15fiscal Q3 2026371120001493152-26-028691
10-Q2026-03-17fiscal Q2 2026371120001493152-26-010385
10-Q2025-12-15fiscal Q1 202636730001493152-25-027749
10-K2025-10-29fiscal FY 202539790001493152-25-020065
10-Q2025-06-16fiscal Q3 2025361070001641172-25-015245
10-Q2025-03-17fiscal Q2 2025351030001493152-25-010576
10-Q2024-12-16fiscal Q1 202535720001493152-24-050227
10-K2024-10-29fiscal FY 202442830001493152-24-042939
10-Q2024-06-14fiscal Q3 2024381070001493152-24-023869
10-Q2024-03-18fiscal Q2 2024381040001493152-24-010313
10-Q2023-12-14fiscal Q1 202437730001493152-23-044859
10-K2023-10-30fiscal FY 202343850001493152-23-038673
10-Q2023-06-14fiscal Q3 202334960001493152-23-021239
10-Q2023-03-17fiscal Q2 202334950001493152-23-008080
10-Q2022-12-14fiscal Q1 202334700001493152-22-035441
10-K2022-10-28fiscal FY 202241800001493152-22-029844
10-Q2022-06-14fiscal Q3 202233920001493152-22-016732
10-Q2022-03-15fiscal Q2 202231870001493152-22-006865
10-Q2021-12-15fiscal Q1 202231650001493152-21-031570
10-K2021-10-28fiscal FY 202145890001493152-21-026623
10-Q2021-06-15fiscal Q3 2021381040001493152-21-014404
10-Q2021-03-15fiscal Q2 202134860001493152-21-006001
10-Q2020-12-15fiscal Q1 202133640001493152-20-023641
10-K2020-10-08fiscal FY 202044880001493152-20-019153
10-Q2020-06-11fiscal Q3 2020381050001493152-20-011005
10-Q2020-03-12fiscal Q2 202034910001493152-20-003816
10-Q2019-12-13fiscal Q1 202033660001493152-19-019180
10-K2019-10-30fiscal FY 201939780001493152-19-016126
10-Q2019-06-13fiscal Q3 201932850001493152-19-009128
10-Q2019-03-06fiscal Q2 201932820001493152-19-002933
10-Q2018-12-13fiscal Q1 201932640001493152-18-017439
10-K2018-10-25fiscal FY 201837750001493152-18-014849
10-Q2018-06-13fiscal Q3 201831780001493152-18-008597
10-Q2018-03-14fiscal Q2 201831780001493152-18-003340
10-Q2017-12-14fiscal Q1 201830610001493152-17-014602
10-K2017-10-26fiscal FY 201734710001493152-17-012096
10-Q2017-06-08fiscal Q3 201734940001493152-17-006329
10-Q2017-03-02fiscal Q2 201729760001493152-17-002066
10-Q2016-12-14fiscal Q1 201730590001493152-16-015867
10-K2016-10-27fiscal FY 201632660001493152-16-014317
10-Q2016-06-09fiscal Q3 201632880001493152-16-010662
10-Q2016-03-09fiscal Q2 201629750001558370-16-003940
10-Q2015-12-10fiscal Q1 201628580001558370-15-002828
10-K2015-10-28fiscal FY 201534690001558370-15-001985
10-Q2015-06-11fiscal Q3 201529760001558370-15-001075
10-Q2015-03-04fiscal Q2 201529740001193125-15-076814
10-Q2014-12-11fiscal Q1 201529580001193125-14-440146
10-K2014-10-28fiscal FY 201431640001193125-14-385128
10-Q2014-06-10fiscal Q3 201430760001193125-14-231930
10-Q2014-03-13fiscal Q2 201430760001193125-14-097672
10-Q2013-12-12fiscal Q1 201429590001193125-13-471757
10-K2013-10-24fiscal FY 201335730001193125-13-409928
10-Q2013-06-14fiscal Q3 201330800001079973-13-000401
10-Q2013-02-25fiscal Q2 201330810001079973-13-000134
10-Q2012-12-11fiscal Q1 201330630001079973-12-000965
10-K2012-10-29fiscal FY 201235720001079973-12-000838
10-Q2012-06-13fiscal Q3 201228720001079973-12-000450
10-Q2012-03-16fiscal Q2 201229740001079973-12-000152
10-Q/A2011-12-22fiscal Q1 201227560001079973-11-001023

Inspect the source

Entity
PURE Bioscience, Inc. / CIK 0001006028
Captured
2026-09-20T05:11:57.608Z
SEC response SHA-256
592f8793cc81bf26bc4a9a52fc6040155bd07f864b81db91b56963966a8209f2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001006028.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))